BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18678501)

  • 1. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
    Ke S; Li Z; Qian X
    Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
    Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
    J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 4H-1,3,4-oxadiazin-5(6H)-ones with hydrophobic and long alkyl chains: design, synthesis, and bioactive diversity on inhibition of monoamine oxidase, chitin biosynthesis and tumor cell.
    Ke SY; Qian XH; Liu FY; Wang N; Yang Q; Li Z
    Eur J Med Chem; 2009 May; 44(5):2113-21. PubMed ID: 19027994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
    J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N'-bis[2-oxo-2H-benzopyran]-3-carboxamides.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Befani O; Turini P; Alcaro S; Ortuso F
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4135-40. PubMed ID: 16759860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors.
    Shi L; Yang Y; Li ZL; Zhu ZW; Liu CH; Zhu HL
    Bioorg Med Chem; 2010 Feb; 18(4):1659-64. PubMed ID: 20117937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.
    Maccioni E; Alcaro S; Cirilli R; Vigo S; Cardia MC; Sanna ML; Meleddu R; Yanez M; Costa G; Casu L; Matyus P; Distinto S
    J Med Chem; 2011 Sep; 54(18):6394-8. PubMed ID: 21777011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.
    Reniers J; Robert S; Frederick R; Masereel B; Vincent S; Wouters J
    Bioorg Med Chem; 2011 Jan; 19(1):134-44. PubMed ID: 21183355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies.
    Khattab SN; Hassan SY; Bekhit AA; El Massry AM; Langer V; Amer A
    Eur J Med Chem; 2010 Oct; 45(10):4479-89. PubMed ID: 20708306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
    Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.
    Santana L; Uriarte E; González-Díaz H; Zagotto G; Soto-Otero R; Méndez-Alvarez E
    J Med Chem; 2006 Feb; 49(3):1149-56. PubMed ID: 16451079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.